Cargando…
Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic Index
BACKGROUND: Immuno-oncology (IO) is rapidly evolving in early drug development. We aimed to develop and prospectively validate a prognostic index for patients treated in IO phase I trials to assist with patient selection. METHODS: The development cohort included 192 advanced solid tumor patients tre...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050022/ https://www.ncbi.nlm.nih.gov/pubmed/32337489 http://dx.doi.org/10.1093/jncics/pkz071 |